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Abstract
The incubation of the gerbil forebrain microsomes in the presence of ferrous sulphate and EDTA for either 30 min or for
60 min at a temperature of 378C led to the inhibition of Ca2q-ATPase in both a concentration- and time-dependent manner.
2q 2q  .The concentrations of Fe which led to the inhibition of 50% of the Ca -ATPase activity IC -value at these times were50
0.59 mM and 0.07 mM, respectively. The preincubation of microsomes with 0.1 mM of stobadine prevented the inhibition of
Ca2q-ATPase, however, the effectivity of prevention was dependent on the Fe2q concentration. The net effect of stobadine
was an increase in IC -value to 0.76 mM. Unlike stobadine, reduced glutathione is a naturally occurring water soluble50
antioxidant. Glutathione at the concentration of 0.1 mM had no significant protective effect on the inhibition of
Ca2q-ATPase. The protective effect of a stobadine–glutathione mixture was also investigated; 0.1 mM of stobadine in
combination with 0.1 mM of glutathione was more potent in prevention of Fe2q-induced inhibition of Ca2q-ATPase than
 .stobadine alone IC s1.31 mM . In addition, we have investigated the effect of various stobadine-glutathione molar ratios50
 . 2q 2qthe total concentration of both antioxidants being 0.2 mM on Fe -induced inhibition of Ca -ATPase. The results
indicated that the best stobadine-glutathione ratio was close to 1 : 1. The effect of 0.04 mM stobadine in combination with
0.16 mM glutathione was comparable to the effect of 0.2 mM of stobadine alone, whereas 0.2 mM glutathione was almost
ineffective. These results may suggest a possible role of membrane in Fe2q-induced inhibition of Ca2q-ATPase. q 1998
Elsevier Science B.V.
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1. Introduction
Cytoplasmic Ca2q acts as a ubiquitous messenger
controlling many different aspects of neuronal cell
w xfunctioning 1 . Its homeostasis is precisely controlled
by various systems including Ca2q-ATPase, which is
localized on the endoplasmic reticulum membrane
) Correspondence address. Fax: q421 842 367 70.
w x 2q2,3 . This ATPase is responsible for Ca sequestra-
 2qtion, leading together with extrusion of Ca to
.extracellular space to the decrease of intracellular
Ca2q concentration to the resting level. Although
iron is a remarkably useful metal in nature, its cyto-
toxicity is mediated by the potency of iron to induce
free radicals and oxidative stress. In the central ner-
vous system, free radicals and oxidative stress are
thought to be involved in the pathophysiology of
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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some neurodegenerative diseases such as Parkinson
w x w xdisease 4,5 , amyotrophic lateral sclerosis 5 ,
w x w xAlzheimer disease 4,6 as well as brain trauma 7 ,
w xischemia-reperfusion injury 8,9 and subarachnoidal
w xhaemorrhage 10 . Activities of several membrane
spanning proteins, including ionic pumps and recep-
tors, are often modulated by the action of free radi-
w x w xcals and oxidative stress 11 . Our previous study 12
provided evidence that the Ca2q accumulation mech-
anism and Ca2qATPase activity in mammalian brain
microsomes are very sensitive to damage induced by
free oxygen radicals generated in-vitro. Since the
inhibition of the Ca2q-ATPase was delayed in com-
parison to the decrease of the Ca2q uptake, we
supposed that the primary effect of free oxygen radi-
cals is alteration of the lipid component of the mem-
brane; leading probably, first to an increase of pas-
sive membrane permeability, and then to the decrease
of Ca2q-ATPase activity. In fact, we have also docu-
w xmented the modification of membrane properties 13
by free oxygen radicals and an increase of passive
w xmembrane permeability 14 . Since it has been sug-
gested that oxidation of protein cannot be excluded,
the aim of this work was to study in more detail the
Fe2q-induced inhibition of gerbil forebrain microso-
mal Ca2q-ATPase. In addition, the protective effects
of stobadine, glutathione, and combination of both
antioxidants had also been investigated.
2. Materials and methods
2.1. Chemicals
 .Stobadine dihydrochloride, - -cis-2,8-dimethyl-
w x2,3,4,4a,5,9b-hexahydro-1H-pyrido 4,3-b indole di-
ˇhydrochloride, was synthetized by the Stolc et al.
w xmethod 15 and was provided through the courtesy
ˇ of Dr. S. Stolc Institute of Experimental Pharmacol-
.ogy, Slovak Academy of Sciences Bratislava . All
other chemicals were of research grade.
2.2. Microsome preparation
The brains of adult gerbils were removed after
decapitation and the cerebrum separated from the
cerebellum and mesencephalon. The microsomal frac-
tion was isolated from the cerebrum according to
w xEdelman et al. 16 with slight modifications. Briefly,
brain tissue was minced into small pieces and ho-
mogenized in 10 vol. of cold buffer A 0.32 M su-
crose, 5 mM Hepes, 0.1 mM phenylmethanesulphonyl
.fluoride, pHs7.4 with a wide-clearance Teflon Pot-
ter–Elvehjem homogenizer. The homogenate was
centrifuged at 900 = g for 10 min. The pellet was
re-homogenized in five volumes of ice cold buffer A
and centrifuged at 900 = g for 10 min. The super-
natants were collected and the crude mitochondrial
fraction was removed by centrifugation at 17 000 = g
for 45 min. The microsomal pellet, which was ob-
tained by centrifugation of post-mitochondrial super-
natant at 100 000 = g for 60 min, was suspended in
10 ml of ice cold buffer A and centrifuged at
100 000 = g for 60 min. All steps were carried out at
48C. The final pellet was suspended in 0.5 ml of ice
cold buffer A to give a membrane protein concentra-
tion of f3 mgrml and was then stored in liquid
nitrogen. Microsome isolated from six independent
membrane preparations were used in this study. The
protein concentration was determined by the Lowry
w x w xet al. method 17 . Edelman et al. 16 demonstrated
that microsomal fraction isolated by this technique
was enriched in endoplasmic reticulum membranes
by utilizing a membrane marker enzyme characteriza-
tion profile.
2.3. Membrane treatment
 .Isolated microsomes 2 mgrml were preincubated
with various amounts of freshly prepared equimolar
FeSO -EDTA solution at 378C for 30 and 60 min.4
The final concentration of the membrane protein was
1 mgrml, and the final concentrations of FeSO -4
EDTA are indicated in the figures. To study the
effect of antioxidants, microsomes were preincubated
with antioxidants for 15 min at 08C prior to the
incubation with FeSO -EDTA. Final concentrations4
of used antioxidants are indicated in the figure and
table legends.
2.4. Ca2q-ATPase measurement
Ca2q-stimulated ATPase activity was determined
by the coupled enzyme assay. Microsomes 10 mg
.per assay were incubated in a medium containing
20 mM HEPES with pH 7.0, 5 mM MgCl , 1 mM2
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EGTA, 5 mM NaN , 0.44 mM phosphoenolpyruvate,3
0.4 mM NADH, 2 mM ATP, 32.5 mg of C E , pyru-12 8
 . vate kinase 10 units and lactate dehydrogenase 22
.units in a total volume of 0.5 ml. ADP production
was monitored by measurement of NADH oxidation
 .at 340 nm Pharmacia LKB Ultrospec III . The
Ca2q-stimulated activity was calculated by subtract-
2q  .ing the activity, in the absence of Ca basal rate ,
from that obtained after addition of the appropriate
concentration of Ca2q to yield the free Ca2q concen-
tration of 10 mM. Free Ca2q concentration was calcu-
lated by Cabuf software, generously provided by Dr.
 .G. Droogmans K.U. Leuven, Belgium .
2.5. E˝aluation of results
The results from experiments measuring the de-
2q  . 2qpendence of Ca -ATPase activity ˝ upon Fe
w 2q x.concentration Fe were best fitted by the follow-
ing equation:
n2q˝s100r 1q Fe rIC . 550
where IC is the concentration of Fe2q which led to50
the inhibition of the Ca2q-ATPase activity to 50% of
control and n the exponent, which resembles the Hill
coefficient; however, its exact meaning is unknown.
The parameters of such a curve were calculated by
computer.
The results were presented as mean"S.E.M. and
the Student’s t-test was used to determine the differ-
ences between the means.
3. Results
The incubation of the gerbil forebrain microsomes
in the presence of FeSO -EDTA for either 30 min or4
for 1 h at a temperature of 378C led to the inhibition
of Ca2q-ATPase in both a concentration- and time-
 .dependent manner Fig. 1 . The calculated IC -val-50
ues were 0.59 and 0.07 mM, respectively, of the
incubation time. The exponents were 3.4"0.1 and
0.84"0.03, respectively.
Stobadine, with known chain-breaking antioxidant
w xproperties 18 , and being both membrane and water
w xsoluble 19 was included into the membranes to
prevent the Fe2q-induced inhibition of Ca2q-ATPase.
The preincubation of microsomes with 0.1 mM of
Fig. 1. Concentration-dependent inhibition of gerbil forebrain
microsomal Ca2q-ATPase by Fe2q. Microsomal membranes were
incubated at 378C for 30 or 60min in the presence of varying
amounts of Fe2q. Ca2q-ATPase activity is expressed as a per-
centage of control activity. The results are shown as mean"
S.E.M. of 4 independent measurements.
stobadine influenced the inhibition of Ca2q-ATPase
2q  .in the Fe concentration-dependent manner Fig. 2 .
While 0.1 mM of stobadine conferred protection of
Fig. 2. Effect of stobadine on the inhibition of gerbil forebrain
microsomal Ca2q-ATPase by Fe2q. Microsomal membranes were
incubated at 378C for 30 min in the presence of varying concen-
trations of Fe2q and 0.1 mM stobadine. Ca2q-ATPase activity is
expressed as a percentage of control activity. The results are
shown as mean"S.E.M. of four independent measurements.
) .p-0.01 significantly different from corresponding parallel
incubated without antioxidant.
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Fig. 3. Effect of glutathione and stobadine–glutathione mixture
on the inhibition of gerbil forebrain microsomal Ca2q-ATPase by
Fe2q. Microsomal membranes were incubated at 378C for 30 min
in the presence of varying concentrations of Fe2q and 0.1 mM
glutathione or 0.1 mM stobadine plus 0.1 mM glutathione. Ca2q-
ATPase activity is expressed as a percentage of control activity.
The results are shown as mean"S.E.M. of four independent
)) .measurements. p-0.001 significantly different from corre-
sponding parallel incubated without antioxidant.
the Ca2q-ATPase at an Fe2q concentration of 0.5 mM
 . 2qp-0.01 , it was almost ineffective at Fe concen-
trations higher than 1 mM. The parameters of the
curve describing the inhibition of Ca2q-ATPase in the
presence of 0.1 mM stobadine have also been calcu-
lated. The net effect of stobadine was the increase of
both, IC -value to 0.76 mM of Fe2q and the expo-50
nent to 5.7"0.2.
Unlike stobadine, reduced glutathione is a natu-
rally occurring water soluble thiol group containing
w xantioxidant 20 . To test the hypothesis that protein
thiol group oxidation may be involved in the process
of ATPase inhibition, we have investigated the possi-
ble protective effect of reduced glutathione alone.
Glutathione at the concentration of 0.1 mM had no
significant protective effect on the Fe2q-induced inhi-
2q  .bition of Ca -ATPase Fig. 3 . Although the IC50
value had been shifted to 0.71"0.01 mM of Fe2q,
all experimental points are not significantly different
in comparison to their corresponding parallels mea-
sured in the absence of antioxidant. Based on these
results, we suppose that the increase of IC is within50
experimental error. The exponent value, 3.1"0.01,
is comparable to that obtained in the case of incuba-
tion without glutathione.
It is well known that combination of membrane
soluble tocopherol with water-soluble ascorbic acid
leads to the profound protection of membranes against
w xlipid peroxidation 20 . The protective effect of stoba-
dine–glutathione mixture was investigated in order to
test the potency of such a mixture to prevent the
2q 2q Ca -ATPase against Fe -induced inhibition Fig.
.3 . We have omitted the usage of ascorbic acid since
its combination with Fe2q may also lead to the
w xpotentiation of lipid peroxidation 20 . A 0.1 mM
aliquot of stobadine in combination with 0.1 mM of
glutathione was more potent in prevention the Fe2q-
induced inhibition of Ca2q-ATPase than stobadine
 .alone IC s1.31"0.01 mM . Under these condi-50
tions, the exponent value also increased to 5.7"0.5.
In addition, we have investigated the effect of stoba-
dine–glutathione mixture with different molar ratios
Fig. 4. Molar ratio-dependent protective effect of stobadine–
glutathione mixture on the inhibition of gerbil forebrain microso-
mal Ca2q-ATPase by Fe2q. Microsomal membranes were incu-
bated at 378C for 30min in the presence of 0.75 mM Fe2q and
varying molar ratios of glutathione and stobadine. The different
molar ratios of both the antioxidants are expressed as molar
w x w x w x. w xfractions of glutathione: GSH r ST q GSH , where GSH is
w xconcentration of glutathione and ST the concentration of stoba-
w xdine. The total concentration of stobadine and glutathione ST q
w x. 2qGSH was 0.2 mM. Ca -ATPase activity is expressed as a
percentage of control activity. The results are shown as mean"
 . S.E.M. of four independent measurements. ) p-0.01 , )) p
.-0.001 significantly different from sample incubated with
w x w x w x. 40.2 mM glutathione GSH r ST q GSH s1 .
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Table 1






q0.1 mM stobadine 198.4"34.4
q0.1 mM glutathione 163.4"4.7
q0.1 mM stobadineq0.1mM 176.8"16.1
glutathione
a Microsomal membranes were preincubated at 08C for 30 min
with antioxidant and then the activities of Ca2q-ATPase were
measured at 378C. The results are shown as mean"S.E.M. of
four triplicate measurements.
of both antioxidants the total concentration of both
. 2qbeing 0.2 mM on the Fe -induced inhibition of
2q  .Ca -ATPase Fig. 4 . An obtained curve indicates
that the best ratio of stobadinerglutathione is close to
1 : 1.
To assess the possible effects of stobadine, glu-
tathione, and combination of both antioxidants to-
gether on Ca2q-ATPase, the activity of ATPase was
measured after preincubation of microsomes with
stobadine without further treatment with Fe2q. As
shown in Table 1, the activity of Ca2q-ATPase mea-
sured under different conditions was slightly differ-
Table 2
Effect of antioxidants on the Fe2q-induced inhibition of gerbil
forebrain microsomal Ca2q-ATPasea
2qCa -ATPase activity
 .% of control
Without antioxidant 34.3"8.7
0.1 mM stobadine 47.9"8.3
b0.2 mM stobadine 68.3"8.1
c0.04 mM stobadineq0.16mM 78.3"9.0
glutathione
d,e0.1 mM stobadineq0.1mM 95.9"3.9
glutathione
0.1 mM glutathione 47.1"11.0
0.2 mM glutathione 30.5"5.0
aMicrosomal membranes were first preincubated at 08C for 30min
with antioxidants and then incubated at 378C for 30 min in the
presence of 0.75 mM FeSO –EDTA. The results are shown as4
mean"S.E.M. of four independent measurements. The values
significantly different from the value obtained after incubation
b c d .without antioxidant p-0.05, p-0.01, p-0.001 and from
e .0.2 mM stobadine value p-0.05 are indicated.
ent; however, these differences were not statistically
significant.
Table 2 summarizes the presented results. The
effect of 0.1 mM stobadine in combination with
0.1 mM glutathione was significantly higher than the
 .effect of 0.2 mM stobadine p-0.05 . The effect of
0.04 mM stobadine in combination with 0.16 mM
glutathione p-0.01, in comparison to the sample
.  .without antioxidant was comparable if not higher
 .to the effect of 0.2 mM stobadine p-0.05 . Both
0.1 mM of stobadine and 0.1 mM of glutathione led
to the increase of Ca2q-ATPase activity, however,
these changes are not statistically significant. Glu-
tathione at a concentrations of 0.2 mM appears to be
almost ineffective.
4. Discussion
Fe2q-induced oxidative stress of neuronal cells is
w ximportant from several points of view 21 . The brain
is an abundant source of iron and several areas of the
brain are enriched in iron content. The capacity of
cerebrospinal fluid to bind iron is poor, therefore the
release of iron by haemorrhage, or its mobilization
from ferritin by acidosis, may trigger lipid peroxida-
tion of neuronal membranes and lead to the damage
to the cells andror death of neurones. In addition,
brain tissue possesses limited natural antioxidant ca-
pacity. Although the central nervous system has a
rather high ascorbic acid content, this property may
not always be beneficial, especially in the case of
Fe2q-induced lipid peroxidation; ascorbate may po-
w xtentiate the cytotoxity of free iron 20 . The artificial
antioxidant intervention is thought to be important in
w xthe treatment of head injury 7 , ischemia-reperfusion
w x w xinjury 22 , Parkinson disease 23 and subarachnoid
w xhaemorrhage 10 . Using gerbil forebrain microsomal
membranes, we examined a model system for Fe2q-
induced inhibition of Ca2q-ATPase and tested the
antioxidant properties of stobadine and glutathione.
Freshly prepared equimolar solution of FeSO -EDTA4
in deionized water has been used in this study. Such
w xsolution, as had been discussed by Rohn et al. 24 ,
contains 92–95% of iron in the form of Fe2q and is
widely used as lipid peroxidation initiator. Since we
have documented earlier that Fe2q-induced lipid per-
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oxidation depresses the maximal velocity of microso-
mal Ca2q-stimulated ATP hydrolysis reaction without
2q w xeffect on the Ca affinity 12 , we measured the
effect of various Fe2q concentrations on inhibition of
Ca2q-ATPase only at saturated concentration of Ca2q.
The incubation of the microsomes with Fe2q-
EDTA led to the inhibition of Ca2q-ATPase activity
in both a concentration- and time-dependent manner.
The prolonged incubation time was with the intention
of investigating the effect of time in correlation with
Fe2q concentration. Although the estimated IC -val-50
ues are far from the physiological concentrations of
non-haem iron, which was found to be 0.074 mgrmg
w xprotein in the brain 25 , our experiments clearly
showed that prolonged incubation time increased the
extend of Ca2q-ATPase inhibition. For comparison,
following preincubation of red blood cells with fer-
rous sulphate and EDTA for 4 h, the NaqrKq-
ATPase, basal Ca2q-ATPase, and calmodulin acti-
vated Ca2q-ATPase were inhibited in a concentra-
tion-dependent manner, with an apparent IC for all50
w xthree ATPases of f0.025 mM iron 24 .
In our previous studies, we published the ability of
stobadine to prevent both, the loss of the rabbit
forebrain endoplasmic reticulum membrane’s effec-
2q w xtivity to sequester Ca 26 and the changes in
w xmembrane integrity 13 due to free-radical attack.
The concentration of stobadine leading to the preven-
2q tion of Ca -accumulation to 50% of control EC -50
.value was as low as 0.012 mM, and stobadine at a
concentration of 0.2 mM conferred full protection
against Fe2q-induced depression of Ca2q-accumula-
w xtion 26 . In this study, we used a fixed concentration
of stobadine while the concentrations of Fe2q were
varied. The effectivity of prevention was dependent
on the Fe2q concentration. Since stobadine is consid-
ered as a potent antioxidant and inhibitor of lipid
w xperoxidation 18 , the results presented in this paper
suggest that, at higher concentrations of Fe2q-EDTA,
the membrane damage is either too extensive so that
addition of 0.1 mM stobadine is not able to prevent
membrane disruption, or that a secondary mecha-
nism, possibly different from lipid peroxidation, is
involved. Production of secondary free radicals has
been documented during the antioxidant action of
 w x.stobadine for a review, see Ref. 18 . It is possible
that such radicals themselves could trigger lipid per-
oxidation presumably with significantly slower kinet-
ics. In comparison, at higher concentrations of iron,
butylated hydroxytoluene also provided only partial
protection of erythrocyte Ca2q-ATPase from Fe3q-in-
w xduced inhibition 27 . The results obtained by Rohn et
w xal. 28 showed that neither butylated hydroxytoluene
nor stobadine were able to confer full defence to the
erythrocyte Ca2q-ATPase against t-butyl peroxide in-
duced inhibition. The ability of thiol compounds to
protect heart and skeletal muscle sarcoplasmic reticu-
lum Ca2q-ATPases from free-radical-mediated inhibi-
w xtion has been documented earlier 29,30 . Based on
these results, we assume that the oxidation of Ca2q-
ATPase protein thiol groups might play a role in
Fe2q-inhibition of gerbil brain Ca2q-ATPase. Al-
though reduced glutathione at a concentration of
0.15 mM was able to protect heart microsomal Ca2q-
w xATPase from thiol oxidation-mediated inhibition 29 ,
inclusion of 0.1 mM reduced glutathione had no sig-
nificant protective effect on brain microsomal Ca2q-
ATPase, and 0.2 mM of glutathione was almost inef-
fective. It seems that with respect to Fe2q-induced
inhibition of brain reticular ATPases, the oxidation of
thiol groups does not play the role, as we suggested
earlier, based on the ineffectivity of hydrogen perox-
ide to inhibit both Ca2q uptake and Ca2q-ATPase
w x12 . On the other hand, the action of thiol com-
w xpounds appears to be controversial. Rohn et al. 28
documented the ability of dithiothreitol to protect
Ca2q-ATPase from t-butyl peroxide induced inhibi-
tion. The initial assumption that the protective effect
of dithiothreitol is caused by reduction of oxidized
Ca2q-ATPase protein thiol groups has not been proven
and the effect has been shown to be mediated by the
action of glutathione peroxidase. The recent study
documented even the involvement of iron-catalyzed
oxidation of thiol compounds in the initiation of free
w xradicals 31 .
Modification of Ca2q-ATPase polypeptide amino
acids could also be considered in the process of
Fe2q-induced inhibition of Ca2q-ATPase. In the pro-
cess of Fe2q-induced enzyme inhibition, Stadtman
w xand Oliver 32 proposed the formation of carbonyl
groups by the mechanism requiring the presence of
hydrogen peroxide. Although the reaction of Fe2q
with oxygen could lead to the formation of hydrogen
w xperoxide 24 earlier presented data documented the
inability of catalase to protect the Ca2q pump of red
w xblood cells 24 and smooth muscle sarcoplasmic
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w xreticulum 33 . Similarly, the recently published pro-
tein fragmentation of the sarcoplasmic reticulum Ca2q
pump has been mediated by Fe2qrH O rascorbate2 2
w x34 . Although other processes leading to the amino
w x 2qacid modifications 35 may also play a role in Fe -
induced inhibition of Ca2q-ATPase, our results con-
cerning combination of stobadine and glutathione
support the view that probably the membrane is a
primary site of Fe2q attack. Inclusion of a glu-
tathione–stobadine mixture significantly protects the
membrane even at such Fe2q concentrations at which
the stobadine alone was ineffective. In support of
this, another possibility exists, that of interaction
between Ca2q-ATPase protein amino acids and mem-
brane-derived compounds produced during the pro-
gression of lipid peroxidation. Although the inhibi-
tion of NaqrKq-ATPase by 4-hydroxynonenal has
w xbeen recently documented 36 , this question in re-
spect of Ca2q-ATPase should be clarified by addi-
tional experiments.
In conclusion, the evidence has been presented that
the incubation of the microsomes with Fe2q-EDTA
led to the inhibition of Ca2q-ATPase activity in both
a concentration- and a time-dependent manner. This
inhibition may be prevented by the inclusion of mem-
brane soluble stobadine, however, the effectivity of
such prevention depends on the Fe2q concentration.
The stobadine effectivity is enhanced by a combina-
tion of stobadine with reduced glutathione. Since
reduced glutathione alone in the concentrations used
is almost ineffective, we suppose that the interaction
between stobadine and glutathione is involved in the
mechanism of enhanced stobadine antioxidant effec-
tivity. The exact mechanism of such an interaction is
not yet clear and several explanations are possible in
this aspect, but they require additional experiments
for clarification. The beneficial action of drug combi-
nations might be very important from the therapeutic
point of view, allowing the decrease of antioxidant
doses and, thus, minimizing their possible side ef-
fects.
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